Aprepitant ameliorates vancomycin-induced kidney injury: Role of GPX4/system Xc− and oxidative damage
Food and Chemical Toxicology · 2025-03 · 197 · 115264
DOI: 10.1016/j.fct.2025.115264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2025-03. Verfasst von Maha H Sharawy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, 35516, Mansoura, Egypt. Electronic address: maha_sharawy@hotmail…. Hauptthemen laut MEDLINE: Acute Kidney Injury, Aprepitant, Glutathione Peroxidase, Oxidative Stress. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, 35516, Mansoura, Egypt. Electronic address: maha_sharawy@hotmail.com.
- Department of Nephrology, Urology and Nephrology Center, Mansoura University, 35516, Mansoura, Egypt.
- Department of Biochemistry, Faculty of Pharmacy, Mansoura University, 35516, Mansoura, Egypt.
Zitieren
APA
Sharawy, M. H., Abdel-Rahman, A. M., & Abdel-Rahman, N. (2025). Aprepitant ameliorates vancomycin-induced kidney injury: Role of GPX4/system Xc− and oxidative damage. Food and Chemical Toxicology, 197, 115264. https://doi.org/10.1016/j.fct.2025.115264
Vancouver
Sharawy MH, Abdel-Rahman AM, Abdel-Rahman N. Aprepitant ameliorates vancomycin-induced kidney injury: Role of GPX4/system Xc− and oxidative damage. Food and Chemical Toxicology. 2025;197:115264. doi:10.1016/j.fct.2025.115264
BibTeX
@article{Sharawy2025,
author = {Sharawy, Maha H and Abdel-Rahman, Ahmed M and Abdel-Rahman, Noha},
title = {Aprepitant ameliorates vancomycin-induced kidney injury: Role of GPX4/system Xc− and oxidative damage},
journal = {Food and Chemical Toxicology},
year = {2025},
volume = {197},
pages = {115264},
doi = {10.1016/j.fct.2025.115264}
}
EUVIMED